Elucidating the specific pharmacological system of action (MOA) of Normally occurring compounds is usually hard. While Tarselli et al. (60) formulated the main de novo synthetic pathway to conolidine and showcased this In a natural way happening compound correctly suppresses responses to equally chemically induced and inflammation-derived pain, the